Melanoma is a leading cause of lost productivity due to premature cancer mortality.
Melanoma frequently spreads to the brain and is associated with rapid deterioration in …

Melanoma brain metastases (MBM) are common and associated with a particularly poor
prognosis; they directly cause death in 60–70% of melanoma patients. In the past, systemic …

Object Following resection of a brain metastasis, stereotactic radiosurgery (SRS) to the
cavity is an emerging alternative to postoperative whole-brain radiation therapy (WBRT) …

Brain metastases show a recurrence rate of about 50% after surgical resection. Adjuvant
radiotherapy can prevent progression; however, whole‐brain radiotherapy (WBRT) can be …

The surgical resection of cerebral metastases is one key element in a multimodal therapy of
brain oligometastatic patients. Standard surgery alone is often not sufficient to achieve local …

Stereotactic radiosurgery (SRS) alone has become one of the treatment options for patients
with 1–4 metastases as the detrimental effects of whole brain radiation therapy on …

Abstract Over the past 15–20 years, stereotactic radiosurgery (SRS) has become the
dominant method for treating patients with brain metastases (BM). The role of surgery for …

Objective The aim of our study is to describe the actual use of corticosteroids in hospitals
that perform stereotactic radiosurgery treatments in Latin America and Spain through a …

Melanoma is the third most common cause of brain metastases, after lung and breast
cancer. The management of melanoma brain metastases can be broadly divided into …

High-grade glioma (HGG) is a primary brain tumour which is associated with a high mortality
rate. An HGG diagnosis is an overwhelming experience for patients and their families, with …